Next Generation Implants Market Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2028 The Global Next Generation Implants (NGI) Market Research Report published by Emergen Research has been formulated by analysis of key business details and extensive geographical spread of the Next Generation Implants (NGI) industry. The market evaluations over the forecast years are based on a comprehensive analysis of the leading market segments, such as product type outlook, application continuum, regional overview, and competitive landscape of the global Next Generation Implants (NGI) market. The report offers a holistic coverage of the Next Generation Implants (NGI) market, laying emphasis on the key factors influencing the industrial growth, technological developments taking place in the industry, and current and emerging trends witnessed in the leading regional markets. The global next generation implants (NGI) market is expected to reach a market size of USD 4.45 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Increasing global geriatric population with rising age-related bone diseases is a key factor driving demand for next generation implants. Major companies are focusing on development of next generation medical implants such as cardiac devices, retinal implants, neurostimulators, and blood pressure sensors, which can bring improvements in patients’ lives and help them to continue their daily activities with least amount of discomfort. Key Companies Profiled in the Report: Abbott Laboratories, Smith & Nephew plc, Johnson & Johnson, Boston Scientific Corporation, C.R. Bard, Inc., Medtronic Public Limited Company, Wright Medical Group N.V, Stryker Corporation, Globus Medical Inc, DENTSPLY SIRONA Inc, and Zimmer Biomet Holdings Inc Gain Access to the Complete Report @ https://www.emergenresearch.com/industry-report/next-generation-implants-market